ClinicalTrials.Veeva

Menu

Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis

T

Tel Aviv Sourasky Medical Center

Status

Terminated

Conditions

Necrotizing Enterocolitis
Sepsis

Treatments

Drug: Probiotics

Study type

Interventional

Funder types

Other

Identifiers

NCT00835874
TASMC-06-SD-363-CTIL

Details and patient eligibility

About

We hypothesize that supplementing maternal diet with probiotics will decrease the incidence of feeding intolerance, necrotizing enterocolitis and sepsis in preterm infants fed breastmilk.

Full description

Oral probiotics have previously been shown to prevent necrotizing enterocolitis in preterm infants. A few reports of sepsis by a probiotic bacteria have impeded implementation of oral probiotic supplementation in most NICUs. Considering the proven immunomodulatory effect of maternal probiotics on breastfed infants of atopic mothers, we would like to explore the indirect effects of maternal probiotics on preterm infants

Enrollment

57 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mothers of preterm infants
  • Pumping breast milk

Exclusion criteria

  • Neonatal congenital anomalies

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems